Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × HER2-positive Colorectal Cancer × regorafenib × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 2 Carcinoma, Hepatocellular 2 Unresectable Locally Advanced or Metastatic Solid Tumors 1 HER2-positive Colorectal Cancer 1 Gastrointestinal Stromal Tumors 1 Cirrhosis, Familial, with Pulmonary Hypertension 1 Cholangiocarcinoma 1

Interventions

regorafenib 1 XELOX 1 HMPL-013 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07384377 2026-02-03

JSKN003 Versus Physician Choiced Treatment in Patients With HER2-positive and Advanced Colorectal Cancer Who Had Failed to Respond to Oxaliplatin, 5-Fu, and Irinotecan

Shanghai JMT-Bio Inc.

Phase 3 Not yet recruiting

Gastrointestinal

HER2-positive Colorectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡